531 related articles for article (PubMed ID: 32998731)
1. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
Kiriazova T; Go VF; Hershow RB; Hamilton EL; Sarasvita R; Bui Q; Lancaster KE; Dumchev K; Hoffman IF; Miller WC; Latkin CA
Harm Reduct J; 2020 Oct; 17(1):69. PubMed ID: 32998731
[TBL] [Abstract][Full Text] [Related]
2. Client and Provider Perspectives on Antiretroviral Treatment Uptake and Adherence Among People Who Inject Drugs in Indonesia, Ukraine and Vietnam: HPTN 074.
Go VF; Hershow RB; Kiriazova T; Sarasvita R; Bui Q; Latkin CA; Rose S; Hamilton E; Lancaster KE; Metzger D; Hoffman IF; Miller WC
AIDS Behav; 2019 Apr; 23(4):1084-1093. PubMed ID: 30306437
[TBL] [Abstract][Full Text] [Related]
3. Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Makarenko I; Mazhnaya A; Polonsky M; Marcus R; Bojko MJ; Filippovych S; Springer S; Dvoriak S; Altice FL
Drug Alcohol Depend; 2016 Aug; 165():213-20. PubMed ID: 27370527
[TBL] [Abstract][Full Text] [Related]
4. Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine.
Zelenev A; Shea P; Mazhnaya A; Rozanova J; Madden L; Marcus R; Altice FL
Drug Alcohol Depend; 2018 Sep; 190():82-88. PubMed ID: 29990648
[TBL] [Abstract][Full Text] [Related]
5. The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.
Bojko MJ; Mazhnaya A; Marcus R; Makarenko I; Islam Z; Filippovych S; Dvoriak S; Altice FL
J Subst Abuse Treat; 2016 Jul; 66():37-47. PubMed ID: 27211995
[TBL] [Abstract][Full Text] [Related]
6. Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine.
Morozova O; Dvoriak S; Pykalo I; Altice FL
Drug Alcohol Depend; 2017 Apr; 173():132-138. PubMed ID: 28242537
[TBL] [Abstract][Full Text] [Related]
7. Utilization of buprenorphine and methadone among opioid users who inject drugs.
Tsui JI; Burt R; Thiede H; Glick SN
Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
[TBL] [Abstract][Full Text] [Related]
8. Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Makarenko I; Mazhnaya A; Marcus R; Bojko MJ; Madden L; Filippovich S; Dvoriak S; Altice FL
Int J Drug Policy; 2017 Jul; 45():56-63. PubMed ID: 28628853
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy.
Kutsa O; Marcus R; Bojko MJ; Zelenev A; Mazhnaya A; Dvoriak S; Filippovych S; Altice FL
J Int AIDS Soc; 2016; 19(4 Suppl 3):20897. PubMed ID: 27435717
[TBL] [Abstract][Full Text] [Related]
10. Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine.
Mazhnaya A; Marcus R; Bojko MJ; Zelenev A; Makarenko I; Pykalo I; Filippovych S; Dvoriak S; Altice FL
J Acquir Immune Defic Syndr; 2018 Nov; 79(3):288-295. PubMed ID: 30312275
[TBL] [Abstract][Full Text] [Related]
11. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
Miller WC; Hoffman IF; Hanscom BS; Ha TV; Dumchev K; Djoerban Z; Rose SM; Latkin CA; Metzger DS; Lancaster KE; Go VF; Dvoriak S; Mollan KR; Reifeis SA; Piwowar-Manning EM; Richardson P; Hudgens MG; Hamilton EL; Sugarman J; Eshleman SH; Susami H; Chu VA; Djauzi S; Kiriazova T; Bui DD; Strathdee SA; Burns DN
Lancet; 2018 Sep; 392(10149):747-759. PubMed ID: 30191830
[TBL] [Abstract][Full Text] [Related]
12. Integrating methadone into primary care settings in Ukraine: effects on provider stigma and knowledge.
Bromberg DJ; Machavariani E; Madden LM; Dumchev K; LaMonaca K; Earnshaw VA; Pykalo I; Filippovych M; Haddad MS; Dvoriak S; Altice FL
J Int AIDS Soc; 2024 Feb; 27(2):e26202. PubMed ID: 38379179
[TBL] [Abstract][Full Text] [Related]
13. Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis.
Lancaster KE; Hoffman IF; Hanscom B; Ha TV; Dumchev K; Susami H; Rose S; Go VF; Reifeis SA; Mollan KR; Hudgens MG; Piwowar-Manning EM; Richardson P; Dvoriak S; Djoerban Z; Kiriazova T; Zeziulin O; Djauzi S; Ahn CV; Latkin C; Metzger D; Burns DN; Sugarman J; Strathdee SA; Eshleman SH; Clarke W; Donnell D; Emel L; Sunner LE; McKinstry L; Sista N; Hamilton EL; Lucas JP; Duong BD; Van Vuong N; Sarasvita R; Miller WC;
J Int AIDS Soc; 2018 Oct; 21(10):e25195. PubMed ID: 30350406
[TBL] [Abstract][Full Text] [Related]
14. Perceived need, barriers to and facilitators of mental health care among HIV-infected PWID in Hanoi, Vietnam: a qualitative study.
Nguyen MX; Go VF; Bui QX; Gaynes BN; Pence BW
Harm Reduct J; 2019 Dec; 16(1):74. PubMed ID: 31878934
[TBL] [Abstract][Full Text] [Related]
15. Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study.
Tan J; Altice FL; Madden LM; Zelenev A
Lancet HIV; 2020 Feb; 7(2):e121-e128. PubMed ID: 31879250
[TBL] [Abstract][Full Text] [Related]
16. Stigma and quality of co-located care for HIV-positive people in addiction treatment in Ukraine: a cross-sectional study.
Sereda Y; Kiriazova T; Makarenko O; Carroll JJ; Rybak N; Chybisov A; Bendiks S; Idrisov B; Dutta A; Gillani FS; Samet JH; Flanigan T; Lunze K
J Int AIDS Soc; 2020 May; 23(5):e25492. PubMed ID: 32372534
[TBL] [Abstract][Full Text] [Related]
17. The role of access to integrated services at opioid agonist treatment sites in reaching 90-90-90 cascade in people who inject drugs in Ukraine: Country-level data.
Meteliuk A; Prokhorova T; Filippovych S; Ompad DC; Zaller N
Drug Alcohol Depend; 2020 Nov; 216():108216. PubMed ID: 32805547
[TBL] [Abstract][Full Text] [Related]
18. Designing an Individually Tailored Multilevel Intervention to Increase Engagement in HIV and Substance Use Treatment Among People Who Inject Drugs With HIV: HPTN 074.
Lancaster KE; Miller WC; Kiriazova T; Sarasvita R; Bui Q; Ha TV; Dumchev K; Susami H; Hamilton EL; Rose S; Hershow RB; Go VF; Metzger D; Hoffman IF; Latkin CA
AIDS Educ Prev; 2019 Apr; 31(2):95-110. PubMed ID: 30917014
[TBL] [Abstract][Full Text] [Related]
19. "They don't like us….": Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study.
Kumar S; Gupte HA; Isaakidis P; Mishra JK; Munjattu JF
PLoS One; 2018; 13(8):e0203262. PubMed ID: 30161255
[TBL] [Abstract][Full Text] [Related]
20. Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?
Panagiotoglou D; Krebs E; Min JE; Olding M; Ahamad K; Ti L; Montaner JSG; Nosyk B
Int J Drug Policy; 2017 Sep; 47():169-176. PubMed ID: 28578865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
